TECH & INNOVATION

Rolapitant reduces nausea and vomiting in Phase III trial

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.

Brains not recognizing an angry expression

Responses of children with attention-deficit/hyperactivity disorder Responses of children with attention-deficit/hyperactivity disorder Inattention, hyperactivity, and impulsive behavior in children with ADHD can result in social problems and they tend to be excluded from peer activities.

Recommended Stories

Real Time Analytics